SOURCES SOUGHT
66 -- UV/Visible Spectrometer
- Notice Date
- 5/29/2009
- Notice Type
- Sources Sought
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- FDA-09-1057460-KP
- Point of Contact
- Karen R. Petty, Phone: 301-827-8774
- E-Mail Address
-
karen.petty@fda.hhs.gov
(karen.petty@fda.hhs.gov)
- Small Business Set-Aside
- Total Small Business
- Description
- Solicitation: FDA-09-1056049 Agency/Office: Food and Drug Administration Project Title: UV/Visible Spectrometer Request for Information (RFI): This is a RFI in accordance with FAR 15.201 (e) to determine the availability and capability of small businesses (including certified 8(a), Small Disadvantaged, and HUBZone firms; veteran and service-disabled veteran-owned small businesses, and women-owned small businesses. This notice is for planning purposes only, and does not constitute an Invitation for Bids, a Request for Proposals, Solicitation, Request for Quotes, or an indication that the Government will contract for the items contained herein. This notice is not to be construed as a commitment on the part of the Government to award a contract, nor does the Government intend to pay for any information submitted as a result of this notice. This RFI is part of a continuous process for obtaining the latest information on the commercial status of the industry with respect to their current and near-term abilities. The information provided herein is subject to change and in no way binds the Government to solicit for or award a competitive contract. It is emphasized that this is a notice solely for planning and informational purposes only and is not be construed as a commitment by the government to enter into a contractual agreement, nor will the government pay for information solicited. The Government does not reimburse respondents for any cost associated with submission of the information being requested or reimburse expenses incurred to interested parties for responses to this RFI. Any responses received will not be used as a proposal. The U.S. Food and Drug Administration (FDA) is solely seeking to identify any sources with capabilities or prior experience that can supply the following: UV/Visible Spectrometer. Objective: As part of our project to study the effectiveness of contact lens solutions, we require the use of a UV/visible spectrometer capable of high speed data acquisition coupled to a stopped-flow sample mixing system. Specifications: The necessary system must include at a minimum: •xenon lamp light source •stopped flow mixer with integral absorption/fluorescence cell, drive pneumatics and acquisition initiation trigger •double monochromator based spectrometer capable of true absorption measurements •suitable detector •computer-based control/data acquisition with kinetic analysis software Specification: Source: •non-ozone producing xenon arc lamp with at least 75 watt output and suitable power supply/igniter Monochromator: •Dual beam subtractive double monochromator capable of with a spectral range of 200-700 nm •No more than RMS noise of 0.00030 AU in 0.001 seconds at 450 nm •No more than RMS noise of 0.00005 AU in 0.5 seconds at 550 nm •Acquisition of data at a rate of at least 1000 pts per 0.5 millisecond Detector •Dual fast photomultiplier tubes and twin A/D convertors with acquisition rate of at least 20 MHz and digital resolution of at least 12 bits •Appropriate power supplies and control electronics for PMT-A/D convertors and appropriate interface to data acquisition system Computer •Suitable computer complete with LCD screen, keyboard and mouse, all necessary cabling and interfaces. •Control/analysis software to allow for kinetic analysis. Stopped-flow mixer/cell: •4mm x 4mm path length (set up for absorbance and fluorescence measurements) •Stopped flow reaction volume adjustable between 40 and 120 microliters •Pneumatically driven syringes •Stop syringe to have millisecond range deadtime (before data sampling can occur) •Safety interlocks to prevent actuation without sample or stop syringes being locked in place. •Readily exchanged for conventional sampling cells RFI Submission Instructions: FDA will not award a contract on the basis of responses nor otherwise pay for the preparation of any information submitted or FDA’s use of such information. Responses will be separated from, and have no bearing on subsequent evaluations of proposals submitted in response to any resulting formal RFP. Eligibility in participating in a future acquisition does not depend upon a response to this notice. Proprietary information is not being solicited. Information considered proprietary, if any, should be identified as such. Responses will be reviewed only by FDA personnel and will be held in a confidential manner. Responses to the RFI should address the following: Companies are encouraged to respond if they have the capability and capacity to provide the services. However, be advised that generic capability statements are not sufficient for effective analysis of respondents' capacity and capability to enable FDA to examine, analyze, review, verify, improve upon existing and develop, if necessary, mechanisms related to food safety and defense (protection) to protect, promote and preserve the public’s health and well-being. Responses shall directly demonstrate the company's capability, experience, and/or ability to marshal resources to effectively and efficiently perform while in compliance with FAR 52.219-14 ("Limitations on Subcontracting"). Part A: Technical and Capabilities--Provide a capability statement describing how your company would provide an UV/Visible Spectrometer. Part B: Cost Estimate--Provide a cost estimate for an UV/Visible Spectrometer. Part C: Organizational Conflict of Interest--If any, provide disclosure of business activities of your company, your affiliates, your team members and affiliates of your team members which create either a conflict of interest or the appearance of a conflict of interest to provide an autoclave. Part D: Security Requirements--At project completion, while the generated data, information and recommendations are considered public property, describe your ability to provide cleared contractor personnel for the project ensuring data accuracy and integrity. Part E: Business Size—Provide your business size, ie. Small businesses (including certified 8(a), Small Disadvantaged, and HUBZone firms; veteran and service-disabled veteran-owned small businesses, and women-owned small businesses. Although anticipated NAICS code is identified in the Fedbizopps posting, all NAICS codes will be reviewed. Part F: Small Business--Describe your ability to meet the requirements in accordance with 52.219.14—Limitation on Subcontracting. Responses shall be: 1.Identified with the RFI number; and include: Company’s name, mailing address, e-mail address, telephone and fax numbers, website address (if available), and the name, telephone number, and e-mail address of a point of contact having the authority and knowledge to clarify responses with Government representatives. 2.No more than ten (10) pages in length; 3.NOT submitted using the marketing materials; 4.Submitted to the email as indicated above. SUBMISSIONS ARE DUE no later than 5:00pm, on Thursday, June 4, 2009, Eastern Standard Time. The RFI response shall be e-mailed to: Karen.petty@fda.hhs.gov. All information received in response to this notice that is marked proprietary will be handled accordingly. FDA makes no implied or in fact contracts by issuing this RFI. Acknowledgement of receipt of responses will not be made, nor will respondents be notified of the FDA’s view of the information received. Do not send any material that requires a non-disclosure agreement or identify information that is business sensitive will not be accepted. Responses to this notice will not be returned. Telephone calls/questions or inquiries will not be accepted.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/FDA-09-1057460-KP/listing.html)
- Place of Performance
- Address: 10903 New Hampshire Ave, Silver Spring, Maryland, 20903, United States
- Zip Code: 20903
- Zip Code: 20903
- Record
- SN01830717-W 20090531/090529235923-2ec3f1f7c0bc0e2873159f6934eae801 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |